Emerging Therapies For Airway Inflammation Hold Promise - Applied Data Research Analyzes The Impact Of New Treatments

Main Category: Respiratory / Asthma
Also Included In: Allergy;  COPD
Article Date: 13 Apr 2007 - 0:00 PDT

email to a friend   printer friendly   opinions  

The inhaled upper respiratory market represents one of the largest categories of drug spending, with continuing growth due to increasing incidence and diagnosis of airway inflammation conditions such as asthma and chronic obstructive pulmonary disease. A number of factors - factors that include new and emerging drug classes, improved delivery technology, and multi-therapy drug products - are converging to change the dynamics of this therapeutic sector.

New drug classes that focus on molecular targets are emerging as important tools for practitioners. Interest is growing among practitioners and their patients for treatments that are capable of delivering two drugs that can act in concert to mitigate the effects of airway inflammation better than a single drug. These combination products pair drugs with different indications to maximize patient relief.

As the number of asthmatics, COPD, and allergy patients continues to grow, the existing upper respiratory tract market franchise will continue to provide unit growth and margins that will fund ongoing research into technology improvements focused on systemic delivery of proteins and peptides as well as novel small molecule therapeutics.

These findings are examined in a new and comprehensive report from Applied Data Research. The report, Asthma, COPD and Allergic Rhinitis: Emerging Therapeutics of Airway Inflammation Diseases, concludes that new and emerging drug combination products with improved efficacy will shift the balance among available treatments and create opportunities for market participants and choices for caregivers and their patients.

About Applied Data

Applied Data Research is a healthcare therapeutics consulting firm focused on medical market strategies, product commercialization, venture development, and market research. We assist medical market participants in achieving their business objectives through the creation of detailed business development strategies, product commercialization programs, and comprehensive market and technology research and analysis.

www.applieddata.org

• Additional
• References
• Citations